Anorexia nervosa and adrenal hormones: a systematic review and meta-analysis.


Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
01 Sep 2023
Historique:
received: 14 04 2023
revised: 02 07 2023
accepted: 08 08 2023
pmc-release: 05 09 2024
medline: 14 9 2023
pubmed: 5 9 2023
entrez: 5 9 2023
Statut: ppublish

Résumé

Anorexia nervosa is a primary psychiatric disorder characterized by self-induced negative energy balance. A number of hormonal responses and adaptations occur in response to starvation and low body weight including changes in adrenocortical hormones. Our objective was to systematically review adrenocortical hormone levels in anorexia nervosa. We searched MEDLINE and EMBASE for studies that reported at least one adrenocortical hormone, including dehydroepiandrosterone (DHEA), DHEA-sulphate (DHEA-S), progesterone, 17-hydroxyprogesterone, pregnenolone, cortisol (serum, urine, cerebrospinal fluid, and hair sample), aldosterone, androstenedione, and testosterone in patients with anorexia nervosa and normal-weight healthy controls from inception until October 2021. Means and standard deviations for each hormone were extracted from the studies to calculate a mean difference (MD). A pooled MD was then calculated by combining MDs of each study using the random-effects model. We included a total of 101 studies with over 2500 females with anorexia nervosa. Mean cortisol levels were significantly higher in anorexia nervosa as compared to normal-weight controls for multiple forms of measurement, including morning cortisol, 12-hour and 24-hour pooled serum cortisol, 24-hour urine cortisol, and after an overnight dexamethasone suppression test. In contrast, mean serum total testosterone and DHEA-S levels were significantly lower among patients with anorexia nervosa. Women with anorexia nervosa have higher cortisol levels and lower DHEA-S and testosterone levels compared to women without anorexia nervosa. This finding is important to consider when evaluating low-weight women for disorders involving the adrenal axis, especially Cushing's syndrome.

Identifiants

pubmed: 37669399
pii: 7260772
doi: 10.1093/ejendo/lvad123
pmc: PMC10498414
doi:

Substances chimiques

Hydrocortisone WI4X0X7BPJ
Aldosterone 4964P6T9RB
Progesterone 4G7DS2Q64Y
Dehydroepiandrosterone Sulfate 57B09Q7FJR

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S64-S73

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD099139
Pays : United States
Organisme : NIH HHS
ID : R01 HD099139
Pays : United States

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of European Society of Endocrinology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Conflict of interest: P.K.F. is a consultant for Regeneron and Xeris Pharmaceuticals.

Références

J Clin Endocrinol Metab. 2001 Jul;86(7):3217-26
pubmed: 11443192
Am J Psychiatry. 1983 Jan;140(1):92-4
pubmed: 6183982
N Engl J Med. 1986 May 22;314(21):1335-42
pubmed: 3010109
J Steroid Biochem. 1980 May;13(5):529-37
pubmed: 7392629
Crit Care. 2002 Oct;6(5):434-8
pubmed: 12398784
Pediatr Endocrinol Rev. 2011 Sep;9(1):463-73; quiz 474-5
pubmed: 22783644
Arch Intern Med. 2005 Mar 14;165(5):561-6
pubmed: 15767533
Med Chem. 2020;16(6):796-811
pubmed: 31291878
Pediatr Endocrinol Rev. 2017 Mar;14(3):302-311
pubmed: 28508601
J Pediatr Adolesc Gynecol. 2007 Feb;20(1):13-8
pubmed: 17289511
J Psychiatr Res. 2018 Mar;98:87-94
pubmed: 29309960
Eur Eat Disord Rev. 2016 Nov;24(6):531-535
pubmed: 27509907
J Clin Invest. 1973 Feb;52(2):304-15
pubmed: 4346006
J Clin Invest. 1966 Apr;45(4):437-49
pubmed: 5949228
N Engl J Med. 1977 Jan 27;296(4):190-3
pubmed: 831089
Endocr Rev. 2018 Dec 1;39(6):895-910
pubmed: 30165608
Clin Endocrinol Metab. 1986 May;15(2):213-28
pubmed: 3013468
Clin Endocrinol (Oxf). 1991 Apr;34(4):305-10
pubmed: 1831739
Vitam Horm. 2018;108:1-28
pubmed: 30029723
Eur J Endocrinol. 2001 Aug;145(2):165-71
pubmed: 11454512
Biol Psychiatry. 1993 Sep 15;34(6):401-6
pubmed: 8218608
J Endocrinol Invest. 2004 May;27(5):436-41
pubmed: 15279075
Endocrinology. 1983 May;112(5):1782-7
pubmed: 6299709
J Bone Miner Res. 2014 Jan;29(1):151-7
pubmed: 23744513
Int J Eat Disord. 2022 Jun;55(6):733-746
pubmed: 35460091
Endocrinology. 1990 Mar;126(3):1569-75
pubmed: 1689654
Nat Rev Endocrinol. 2020 May;16(5):284-296
pubmed: 32203405
Cell Metab. 2010 Jun 9;11(6):517-31
pubmed: 20519123
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
J Pediatr. 1993 Aug;123(2):326-31
pubmed: 8345437
J Pediatr. 2002 Jul;141(1):64-70
pubmed: 12091853
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Clin Endocrinol Metab. 2008 May;93(5):1526-40
pubmed: 18334580
J Clin Endocrinol Metab. 1989 Mar;68(3):548-54
pubmed: 2493036
Endocr Rev. 2015 Oct;36(5):526-63
pubmed: 26213785
J Clin Psychiatry. 2007 Jun;68(6):959-65
pubmed: 17592924
Nihon Naibunpi Gakkai Zasshi. 1991 Jan 20;67(1):50-5
pubmed: 2013346
Int J Eat Disord. 2005;37 Suppl:S2-9; discussion S20-1
pubmed: 15852310
Calcif Tissue Int. 1990 May;46(5):305-8
pubmed: 2110853
J Clin Endocrinol Metab. 2000 Jan;85(1):183-92
pubmed: 10634385
J Clin Endocrinol Metab. 1996 Oct;81(10):3441-7
pubmed: 8855781
J Bone Miner Res. 1992 Dec;7(12):1467-74
pubmed: 1481732
Clin Biochem. 2009 Aug;42(12):1205-17
pubmed: 19414006
Horm Metab Res. 1988 Jan;20(1):57-60
pubmed: 2836285
J Adolesc Health. 2019 Oct;65(4):462-468
pubmed: 31227390
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4347-4355
pubmed: 31219558
J Clin Endocrinol Metab. 2015 Sep;100(9):3313-21
pubmed: 26171799
J Clin Endocrinol Metab. 2011 Jul;96(7):2081-8
pubmed: 21525157
Compr Physiol. 2014 Oct;4(4):1369-81
pubmed: 25428847
N Engl J Med. 2009 May 28;360(22):2310-8
pubmed: 19474428
J Clin Endocrinol Metab. 1985 May;60(5):947-52
pubmed: 3156871
J Clin Endocrinol Metab. 2007 Apr;92(4):1334-9
pubmed: 17284620
Lancet. 2015 Aug 29;386(9996):913-27
pubmed: 26004339
J Clin Endocrinol Metab. 2004 Oct;89(10):4972-80
pubmed: 15472193

Auteurs

Subhanudh Thavaraputta (S)

Neuroendocrinology Unit, Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, United States.
Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Chulalongkorn University and Excellence Center in Diabetes, Hormone, and Metabolism, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand.

Patompong Ungprasert (P)

Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44195, United States.

Selma F Witchel (SF)

Division of Pediatric Endocrinology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, United States.

Pouneh K Fazeli (PK)

Neuroendocrinology Unit, Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH